Cargando…
TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model
The renin-angiotensin system (RAS), which plays an important role in the progression of heart failure, is efficiently blocked by the inhibition of renin, the rate-limiting enzyme in the RAS cascade. In the present study, we investigated the cardioprotective effects of TAK-272 (SCO-272, imarikiren),...
Autores principales: | Hara, Tomoya, Nishimura, Satoshi, Yamamoto, Toshihiro, Kajimoto, Yumiko, Kusumoto, Keiji, Kanagawa, Ray, Ikeda, Shota, Nishimoto, Tomoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084973/ https://www.ncbi.nlm.nih.gov/pubmed/30092100 http://dx.doi.org/10.1371/journal.pone.0202176 |
Ejemplares similares
-
Discovery of TAK-272: A Novel, Potent, and Orally
Active Renin Inhibitor
por: Imaeda, Yasuhiro, et al.
Publicado: (2016) -
Development of a novel murine heart failure model overexpressing human renin and angiotensinogen
por: Hara, Tomoya, et al.
Publicado: (2020) -
A Randomized, Single‐Center, Double‐Blind, Placebo‐Controlled Multiple‐Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male Subjects
por: Matsuno, Kumi, et al.
Publicado: (2018) -
Health Tract, No. 272: Typhoid
Publicado: (1868) -
Regulation of the (pro)renin–renin receptor in cardiac remodelling
por: Mahmud, Hasan, et al.
Publicado: (2012)